Chinese Influenza Weekly Report

Similar documents
Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Influenza Surveillance Summary: Denton County Hospitals and Providers 17.51% 15.95% 10.94% 7.41% 9.01% 8.08%

Surveillance Overview

Influenza Situation Update

RESPIRATORY VIRUS SURVEILLANCE REPORT

Influenza Update N 157

Influenza Global Epidemiologic Update

Summary. Week 11/2017 (13 19 March 2017) Season overview

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 26, 2018

Questions and Answers

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Influenza surveillance summary

Influenza Update N 159

Community and Hospital Surveillance

Influenza Situation Update


Influenza Situation Update

Influenza Situation Update

GIHSN-China s experience & Results of season Beijing, China

Seasonal Influenza Report

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season

Influenza Activity Update

Seasonal Influenza Report

Influenza Situation Update

Influenza Situation Update

Table 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component

Alberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch

Influenza Surveillance in Ireland Weekly Report Influenza Week (11 th 17 th December 2017)

Summary. Week 15/2018 (9 15 April 2018) season overview

Influenza Prevention Update

Risk assessment of seasonal influenza - Update, EU/EEA, January 2017

Bi-weekly Influenza Situation Update

Summary. Week 4/2018 (22 28 January 2018) season overview

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

Influenza Surveillance in Ireland Weekly Report Influenza Week (22 nd 28 th January 2018)

Seasonal Influenza Report

Summary. Week 13/2018 (26 31 March 2018) season overview

Alberta Health. Seasonal Influenza in Alberta Season. Analytics and Performance Reporting Branch

Weekly Influenza Report

Main conclusions and options for response


Texas Influenza Summary Report, Season (September 28, 2008 April 11, 2009)

REPORT. Early risk assessment: What to expect of the 2017/18 influenza season in Norway

British Columbia Influenza Surveillance Bulletin Influenza Season , Number 23, Weeks August 13 to September 23, 2017

RAPID RISK ASSESSMENT. Risk assessment of seasonal influenza, EU/EEA, Conclusions and options for response. Update, 25 January 2017

NC IMMUNIZATION COALITION FLU THEN AND NOW NC DHHS COMMUNICABLE DISEASE BRANCH ANITA VALIANI, MPH AUGUST 1, 2018

Influenza Update N 176

Week 11 (Mar.13 19, 2016)

Manitoba Health, Healthy Living and Seniors (MHHLS) Week 9 (Feb.28 Mar.5, 2016) == Severe outcomes associated with. == Cases and cumulative incidence

Weekly Influenza Report

Seasonal Influenza Report

WEEKLY INFLUENZA REPORT

Week 11: March 11 to March 17, 2018

Week 15: April 8 to April 14, 2018

British Columbia Influenza Surveillance Bulletin

Week 43 (Oct , 2016)

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th March 2018)

Influenza Weekly Surveillance Bulletin

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

Influenza Activity in Indiana

WEEKLY INFLUENZA REPORT

Influenza vaccine Revisiting Old and Addressing Current Issues. Dr. Leilani T. Sanchez, DPPS, DPIDSP Manila, 18 February 2016

Influenza Weekly Surveillance Bulletin

INFLUENZA WEEKLY UPDATE 2014/25: June 2014

Weekly Influenza Report

SARI, Influenza and Respiratory Pathogens

Influenza Surveillance in Ireland Weekly Report Influenza Weeks 13 & (26 th March 8 th April 2018)

Seasonal Influenza Report

ARIZONA INFLUENZA SUMMARY

Influenza Weekly Surveillance Bulletin

Community and Hospital Surveillance

Summary. Primary care data. Week 49/2014. Season

Local Influenza Surveillance Bulletin Released October 31, 2016

Summary: Decreasing. Since Sept. 1, 2017: Hospitalizations: 363 ICU* admissions: 26 Deaths: 32

Alberta Health. Seasonal Influenza in Alberta. 2012/2013 Season. Surveillance and Assessment Branch. November Government of Alberta 1

Western Pacific Regional Office of the World Health Organization.

WEEKLY INFLUENZA REPORT

Summary: Low activity

Summary: Increasing Activity

Incorporating virologic data into seasonal and pandemic influenza vaccines

Summary: Low activity

Manitoba Influenza Surveillance Report

Manitoba Influenza Surveillance Report 2012/2013 Season

Next report date: May 27 (May 8 21)

WEEKLY INFLUENZA REPORT

MA Adult Immunization Coaltion Flu Update September 28, 2016

Summary: Sustained Influenza B Activity

Weekly influenza surveillance overview

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

Influenza and other Respiratory Viruses Update

Influenza Weekly Surveillance Bulletin

INFLUENZA WEEKLY UPDATE 2014/27: 30 June 6 July 2014

November 5 to 11, 2017 (Week 45)

Weekly Influenza News 2016/17 Season. Communicable Disease Surveillance Unit. Summary of Influenza Activity in Toronto for Week 43

Transcription:

Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 5, influenza activity is at intra-seasonal levels both in southern and northern China with A(H3N2) virus epidemic, but it showed a trend of downward recently. Among influenza viruses antigenically characterized by CNIC since September, 2016, 50(100%) influenza A(H1N1)pdm09 viruses were characterized as A/California/7/2009-like; 181(61.1%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like,287(97%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 151(100%) influenza B/Victoria viruses were characterized as B/Brisbane/60/2008-like; 51(92.7%) influenza B/Yamagata viruses were characterized as B/Phuket/3073/2013-like. Among the influenza viruses tested by CNIC for antiviral resistance analysis since September, 2016, all influenza A(H1N1)pdm09 and all influenza A(H3N2) viruses were resistant to adamantine; All influenza A(H1N1)pdm09 and all influenza H3N2 and B viruses were sensitive to neuraminidase inhibitors. 1

Outbreak Surveillance During week 5(Jan 30 th - Feb 5 th, 2017), there was one outbreak reported nationwide,it was A(H3N2). Surveillance of outpatient or emergency visits for Influenza-like Illness (ILI) During week 5, the percentage of outpatient or emergency visits for ILI (ILI %) at national sentinel hospitals in south China was 3.5%, higher than last week the same week of 2015 and 2016(3.3% 3.1% and 3.0%). (Figure 1) Figure 1. Percentage of Visits for ILI at Sentinel Hospitals in South China (2012-2017) During week 5, ILI% at national sentinel hospitals in north China was 4.0%, lower than last week and the same week of 2016(both 4.2%),higher than the same week of 2015(3.0%). (Figure 2) 2

Figure 2. Percentage of Visits for ILI at Sentinel Hospitals in North China (2012-2017) Virologic Surveillance During week 5, influenza network laboratories tested 6253 specimens, of which 1006(16.7%) were positive for influenza, influenza A and influenza B viruswere 967(96.1%) and 39(3.9%), respectively (Table 1). During week 5, the percentage of specimens that were tested positive for influenza in south China was 10.3%, which was lower than the previous week (12.3%) (Figure 3).During week 2, the percentage of specimens that were tested positive for influenza in north China was 23.0%, which was higher than the previous week (22.0%)(Figure 4). Table 1 Laboratory Detections of ILI Specimens (Week 5, 2017) Week 2 South China North China Total No. of specimens tested 3402 2851 6253 No. of positive specimens (%) 349(10.3%) 657(23.0%) 1006(16.1%) Influenza A 318(91.1%) 649(98.8%) 967(96.1%) A(H3N2) 279(87.7%) 493(76.0%) 772(79.8%) A(H1N1)pdm09 33(10.4%) 152(23.4%) 185(19.1%) 3

A (subtype not determined) 6(1.8%) 4(0.6%) 10(1.0%) Influenza B 31(8.9%) 8(1.2%) 39(3.9%) B (lineage not determined) 3(9.7%) 0(0%) 3(7.7%) Victoria 25(80.6%) 8(100%) 33(84.6%) Yamagata 3(9.7%) 0(0%) 3(7.7%) Figure 3. Influenza Positive Tests Reported by Southern Network Laboratories (Week 14, 2015 Week 5, 2017) Note: Analysis in this part was based on the test results of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. 4

100 50 0 19 26 33 40 3 2 1 0 Figure 4. Influenza Positive Tests Reported by Northern Network Laboratories (Week 14, 2015 Week 5, 2017) Note: Analysis in this part was based on the result of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. Antigenic Characterization Since September 1 st, 2016, all of the 50 A(H1N1)pdm09 viruses tested were characterized as A/California/7/2009-like;181(61.1%) of the 296 A(H3N2) influenza viruses tested were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like, 287(97%) of the 296 A(H3N2) influenza viruses tested were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; all of the 151 influenza B/Victoria lineage viruses tested were characterized as B/Brisbane/60/2008-like; 51(92.7%) of the 55 influenza B/Yamagata lineage viruses tested were characterized as B/Phuket/3073/2013-like. Antiviral Resistance Since September 1 st, 2016, among the influenza viruses tested by CNIC for antiviral resistance, all influenza A(H1N1)pdm09 and all influenza A(H3N2) viruses were resistant to adamantine ; All influenza A(H1N1)pdm09 and all influenza A(H3N2) and B viruses were sensitive to neuraminidase inhibitors. 5